Silver School of Social Work, New York University, New York, New York 10003, USA.
J Addict Dis. 2010 Apr;29(2):127-38. doi: 10.1080/10550881003684582.
Substance use was considered to be primarily a male problem, and many substance abuse studies are conducted with a predominance of male participants. However, recent substance abuse research indicates significant gender differences in the substance-related epidemiology, social factors and characteristics, biological responses, progressions to dependence, medical consequences, co-occurring psychiatric disorders, and barriers to treatment entry, retention, and completion. The epidemiology of women's drug use presents challenges separate from those raised by men's drug use. A convergence of evidence suggests that women with substance use disorders are more likely than men to face multiple barriers affecting access and entry to substance abuse treatment. Gender-specific medical problems as a result of the interplay of gender-specific drug use patterns and sex-related risk behaviors create an environment in which women are more vulnerable than men to human immunodeficiency virus. Individual characteristics and treatment approaches can differentially affect outcomes by gender. All of these differences have important clinical, treatment, and research implications.
药物使用被认为主要是男性的问题,许多药物滥用研究主要以男性参与者为主。然而,最近的药物滥用研究表明,在与物质相关的流行病学、社会因素和特征、生物学反应、依赖进展、医疗后果、共病精神障碍以及治疗进入、维持和完成的障碍方面,存在显著的性别差异。女性药物使用的流行病学提出了与男性药物使用不同的挑战。越来越多的证据表明,患有药物使用障碍的女性比男性更有可能面临多种障碍,这些障碍影响她们获得和进入药物滥用治疗的机会。由于性别特异性药物使用模式和与性别相关的风险行为的相互作用导致的特定于性别的医疗问题,使女性比男性更容易受到人类免疫缺陷病毒的影响。个体特征和治疗方法可能会因性别而异而对结果产生不同的影响。所有这些差异都具有重要的临床、治疗和研究意义。